DESPITE ITS WinE USE, there is a paucity of data concerning the effects of nitrous oxide alone on the heart and peripheral vascular system. This is especially true with regard to the influence of the gas on the intact, innervated, unanaesthetized cardiovascular system. Indeed, there are no reports of dose-response effects of nitrous oxide on cardiovascular dynamics in unintubated, unanaesthetized man or animals, and what data are available studying one or two concentrations of the agent are controversial. Thus, while some reports indicate that nitrous oxide does depress myocardial contractility, 1-:t others do not. 4,~ Similarly, depression, stimulation and no change in haemodynamics have all been reported in studies employing a variety of concentrations of the gas in unanaesthctized and quasi-unanaesthetized dogs and man} -~ Reasons for these different results are not entirely clear but are probably related to: a variety of experimental protocols; the relative impotency of nitrous oxide and, therefore, absence of dramatic cardiovascular changes with its employment under most circumstances; ease of modifying subtle cardiovascular changes produced by the gas with simultaneous use of other anaesthetics, intubation or positive pressure respiration; difficulty in stndying impotent inhalation anaesthetics in animal preparations; and the necessity of using invasive techniques to measure adequately the subtle changes produced by the gas in man.
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A number of recent reports from this laboratory ~;,v have demonstrated the value of the bovine artificial heart (AH) model in investigations of cardiovasculaa'ly active phamnacological compounds. Besides docility and ease of handling and intrumentation, this model enables investigation of drug action in animals under no pharmacological or physiological influence such as anaesthesia, upper airway intubation or artificial respiration, which could modify the cardiovascular manifestations of the compound under investigation. In addition and equally important, utilization of an animal before and after implantation of an artificial heart for anaesthetic investigation allows quantitation and separation of the effects of the anaesthetic on the pheripheral vascular system after AH replacement from its effects on the heart plus the peripheral vascular system before AH replacement. In this study the bovine AH model was used to investigate and differentiate the cardiac and systemic vascular actions of increasing concentrations of nitrous oxide.
M ETHODS
The experimental subjects were 15 unanaesthetized 85 to 104 kg bull calves. After anaesthetic induction with 3 to 5 mg/kg of intravenous sodium methohexital, intubation and maintenance of anaesthesia with intermittent doses of ketamine 2 to 3 mg/kg and doses of succinylcholine 0.5 mg/kg intravenously, each animal had a 10-gauge needle placed percutaneously into the right external jugular vein. With continuous pressure recording, a 7 Fr Swan-Ganz triple lumen catheter was threaded through the needle, through the right ventricle and into the proximal pulmonary artery (PA). Another catheter (14 Fr) was placed percutaneously into the opposite jugular vein and threaded into the right atrium. Following this, a small neck incision was made and a third catheter (17 Fr) threaded down the right or left common carotid artery into the central aorta. Catheter position was documented by continuous pressure recording and catheter patency was maintained with a dilute heparinized (2 units/ml) lactated Ringer's solution which was administered at a rate of 1 to 2 ml/hr by a constant infusion pump. Anaesthesia was then terminated and the animal extubated and allowed to recover for 24 to 48 hours.
ABBREVIATION'S HR = heart rate PA = pulmonary artery RA = right atrial LA = left atrial = cardiac output SV = stroke volume pHa = pH of arterial blood pHV = pH of pulmonary artery (mixed venous) blood PVo~ = partial pressure of oxygen in pulmonary artery blood Pao~ = partial pressure of oxygen in arterial blood Paco.~ = partial pressure of carbon dioxide in arterial blood P~co~ = partial pressure of carbon dioxide in pulmonary artery blood SVR = systemic vascular resistance PVR = pulmonary vascular resistance AH = artificial heart NH --natural heart AH Calves = calves with an artificial heart NH Calves ---calves with their natural heart ~' = minute ventilation
Study procedures before artiIicial heart implantation
Study procedures before artificial heart (AH) implantation were accomplished with the calves lying down, restrained with ropes in a metal calf cage, and breathing through a special calf face mask. In ten calves a Wright Sph'ometer was attached to the inspiratory portal of the face mask allowing minute ventilation ((r) to be measured. Aortic and pulmonary artery (PA) blood samples were drawn for blood gas (oxygen and carbon dioxide tension) analysis and pH and haemoglobin determinations while the calves were breathing room air. Heart rate (HR), mean aortic, PA and right atrial (R.A) blood pressures and ~" were then recorded and a dye dilution cardiac output (QT) determination was made using indocyanine green dye and a Waters Instruments, Inc. DCR-702 cardiac output computer system. Following this, the animals were allowed to breathe 100 per cent oxygen for 20 minutes. The face mask was attached to a standard 5-1itre semi-closed anaesthesia circle system equipped with soda-lime carbon dioxide absorption canisters, a Wright spirometer, and one-way breathing valves. Inspiratory gases were delivered to the circle system at the rate of 10 I/min from recently calibrated Ohio rotameter flowmeters. After a 20-minute equilibration period with 100 per cent oxygen, aortic and PA blood samples were drawn for blood gas and pH analysis, HR and aortic, PA and RA blood pressures were again recorded, V re-measured and QT re-determined. After this, the calves were given 10 per cent nitrous oxide in oxygen and after 20 minutes the data were again collected. Nitrous oxide was then increased to 20 per cent and after 20 minutes the data were collected again. In a similar fashion data were collected after 30, 40, 50, 60, and 70 per cent nitrous oxide and then again following breathing 100 per cent oxygen for 20 minutes.
Blood carbon dioxide tension was measured with a Severinghaus electrode, pH with a Radiometer glass electrode and oxygen tension with a modified Clark electrode. All electrodes were maintained at 390 C (normal body temperature for a calf) and frequently re-calibrated with standard solutions and gases of known concentration and tension.
Systemic vascular resistance (SVR) in dynes -see/cm -~ was calculated from the following equation: SVR = mean aortic pressure-mean RA pressure X 80 Stroke volume (SV) was calculated by dividing (~T by HR. Two to four days later each calf had its natural heart (NH) replaced with a pneumatically driven AH.
Design of the artificial heart and the artificial heart driving system
A silicone rubber (Silastic)* or polyurethane-elliptical type of AH was used in these investigations. This type of AH has been previously described, s-12 It is composed of four chambers (two artificial atria and two artificial ventricles), contains four Bjork-Shiley pyrolytic carbon disc valves and weighs approximately 300 g. Each ventricle consists of a rigid outer casing and a pliable inner bloodcontaining chamber between which compressed air is applied for compression and ejection of blood.
An intrinsic system of AH control based on the maintenance of relatively normal atrial pressures was used in all the experiments. This type of control system has been previously described, s Basically, it consists of two direct-acting three-way solenoid *Silastie, silicone rubber of the Dow-Corning Company of Midland, Mich.
valves, located in the control module, which apply compressed air through the two air drive lines during systole and exhaust air to the atmosphere during diastole. The two air-drive lines bring compressed air from the control module (standing next to the calves' cage) through the calves' chest wall to the AH ventricles within the calves' chest. With this system the rate of filling and, therefore, the volume of blood entering each ventricle during the diastolic period increases with an increase in atrial pressure. This volume is expelled during the next ventricular systole. As filling of the ventricle diminishes, so does stroke volume. There is thus an inherent balance between the pulmonic and systemic circulatory systems, as with the natural heart, and extremes of high and low atrial and venous pressures abe avoided. The AH also responds, as does the NH, to increases and decreases in systemic vascular resistance with appropriate decreases or increases in venh'icular stroke volume and cardiac output.
Protocol and study procedures after artificial heart implantation
Artificial heart implantation was accomplished through a right.lateral .thoracotomy as has been previously described. :* Post-AH !mplantatiou studies (vere initiated 6 to 9 days after operation when tidal volume was >400 ml, Paco.., <2t0 tort and Pao2 > 60 torr for six or more hours while breathing room air. Additional criteria for acceptance in the .study i,leluded mean aortic, PA and RA pressures within 20"per cent of pre-AH.leve!s when AH output was adjusted (by AH rate changes) to approximate pre-implantati'on values. Whel~ these requirements were met, and with the animals lying in tlae metal calf cage, pre-AH implantation study procedures were repeated.
Mean LA pressure was an additional parameter available for measurement after AH implantation. The latter was obtained, as were RA, PA and aortic pressures and blood samples, from high pressure tubing connected to taps on the artificial atria and vascular grafts attaching the artificial ventricles to the natural PA and aorta. With LA pressure it was possible to calculate pulmonary vascular resistance (PVR) in dynes-sec/cm -5 after AH implantation using the following equation:
Changes in all variables with nitrous oxide were compared to room air and 100 per cent oxygen using Student's paired t-test. Comparison of variables in NH and AH groups at a given concentration were made using Student's unpaired t-test. P < 0.05 was considered statistically significant.
RESULTS
Mean values of aortic and PA, Po.,, Pco.., and pH during the entire study appear in Tables I and II . Aortic and PA, P~, Pco.., and pH were not significantly different in NH and AH calves during similar situations throughout the study.* Breathing * Utilizing Student's unpaired t-test. PULI~ONARV ARTERV
BLOOD GAS AND eH CHANGES DURfNG NITROUS OXIDE BREATm~'G IN CALVES (MEAN -4-

SD)
Percent N20 in oxygen 100 per cent oxygen did not significantly alter pulmonary artery pH (pH7 in NH or AH calves but did depress, P < 0.05, aortic pH (pHa) and increase Pao2 and P~;co., in both groups of animals. When compared to 100 per cent oxygen breathing nitrous oxide decreased Pao2 (~rst significant, P < 0.05, at 30 per cent), pHa and pI-IV (significant at 60 per cent) and increased Paco2 and P~co2 (first significant at 50 per cent) in NH and AH calves. Repeat 100 per cent oxygen breathing resulted in a return of aortic and PA blood gases and pH to values similar to those obtained immediately before breathing nitrous oxide in both groups of animals.
890-SVR
NH and AH calves sustained significant, P < 0.05, and similar increases in SVR (- Figure 1 ) and decreases in PA pressure and Qw ( Figures 2 and 3 ) upon breathing FIcum~ 2. Mean aortic and pulmonary artery blood pressure (mean ~ SD) during room ai," breathing, following 100 per cent oxygen and then increasing concentrations of nitrous oxide in oxygen. LP < 0.05, Student's paired t-test when compared to room air, P < 0.05, Studrnt's paired t-test when compared to 100 per cent oxygen (after room air) 9 P < 0.05, ShJdent's unpaired t-test when compared to changes from 100 per cent oxygen (after room air) at the same concentration of nitrous oxide in NH calves. 
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FIGURE 3. Cardiac output (lnean + SD) during room air breathing, following a00 t~er ccnt oxygen and then increasing concentnitions of nitrous oxide in oxygen. Symbols are the same as in Figure 2 . ROOM AIR IOJ%C~ 2 I0%1N20 20%N20 50%N20 40%N20 50%N20 60%N20 70%N20 I00%02
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FIGURE 6. Pulmonary vascular resistance (mean -SD) during room air breathing following 100 per cent oxygen and then increasing concentrations of nitrous oxide. Symbols are the same as in Figure 2. 14- fixed in NH animals). ~1 was slightly decreased during pure oxygen breathing ill both NH and AH calves, Figure 8 .
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Nitrous oxide significantly increased ~r, QT, SV and mean aortic, PA and RA pressures in both NH and AH calves but did not significantly change SVR. Heart rate was increased in NH animals but, as mentioned above, was fixed in AH animals. AH calves experienced an increase in LA pressure dining nitrous oxide breathing but no change in PVR at any concentration of nitrous oxide. Elevations in HR and (~T at nitrous oxide concentrations >30 per cent and aortic pressure at 70 per cent nitrous oxide were significantly greater in NH than AH animals (P < 0.05).
In both groups of animals repeat 100 per cent oxygen breathing resulted ill a return of all cardiovascular variables, with the exception of SV in NH calves, to values not significantly different from those obtained immediately prior to nitrous oxide breathing.
DISCUSSION
The llndings of this study using the bovine AH model, demonstrate that increasi, ng concentrations of nitrous oxide produced significant increases in V, SV, HR, QT and aortic, RA and puhnonary artery blood pressure in unanaesthetized, spontaneously breathing NH calves. These changes, although generally less marked, also occur when AH calves breathe nitrous oxide and are accompanied, as they are in NH calves, by small increases in arterial and mixed venous Pco., and decreases in pH. Our results suggest, therefore, that high concentrations of nitrous oxide produce significant cardiovascular stimulation when employed as the sole anaesthetic in spontaneously breathing animals. Finally, the data demonstrate that nitrous-oxide-induced cardiow~scular stimulation is secondary to both improved venous return to the heart, i.e. a Frank Starling effect, as well as increased myocardial chronotropy.
Cardiovascular stimulation, as manifested by elevations in HR, arterial and venous blood pressures, SVR, SV o1' QT, have, as mentioned previously, been described by some authors xd~en nitrous oxide is breathed alone 5 or when the gas is added to halothane-oxygen anaesthesia, a3,14 These changes, when observed, have usually been attributed to increased sympathetic activity. Eisle and Smith'-' found that 40 per cent nitrous oxide tended to increase plasma norepinephrine and, occasionally, epinephrine in unanaesthetized supine man. Smith and co-workers ~a demonstrated even greater elevations in plasma norepinephrine when 70 per cent nitrous oxide was administered to volunteers equilibrated with 1.5 to 2.0 per cent halothane and oxygen.
It is not entirely clear how nitrous oxide increases sympathetic activity. Proposed mechanisms have included increased rate of catecholamine synthesis; blockade of active transport from extracellular fluid to the cytoplasmic mobile pool, causing augmentation of norepinephrine from the cytoplasmic mobile pool, leading to a sympathomimetic effect (tyramine-like effect); inhibition of catechol-omethyl transferase or active release from the intragranular mobile pool (guanethidine-like effect).la There is also evidence that it is not nitrous oxide but rather decreases in oxygen which are responsible for sympathetic stimulation. ~3.1~ The present study does not establish which one or combination of these mechanisms applies. However, it does suggest that at least a component of the increased sympathetic stimulation that occurs during nitrous oxide administration may be due to concomitant increases in Pa~.o._, and/or Pvcoo_. An increase in Paco, may be explained by nitrous-oxide-induced respiratoi'y depression. However, minute ventilation was increased by nitrous oxide in this study and returned to values not significantly different from room air or 100 per cent oxygen controls, with return to breathing pure oxygen. Indeed, respiratory depression has never been reported with clinical concentrations ( 10 to 70 per cent) of nitrous oxide in oxygen. Hornbein, et al. found that 70 per cent nitrous oxide also produced a small increase in minute ventilation when added to volunteers equilibrated with halothane (0.8 per cent) in oxygen.
We are unaware of any previous study in which Pvco_~ was measured before and during administration of nitrous oxide. However, increases in Pacoo_ have been described with nitrous oxide anaesthesia when the gas has been used without other i,dmlation anaesthetics as well as when it has been added to halothaneoxygen anaesthesia. ~:~,~4,~" Possible explanations for increases in Paco, upon addition of nitrous oxide could include the second gas effect of nitrous oxide on alveolar Pco._,, an increase in physiological dead space or that nitrous oxide produces enough sympathetic stimulation to increase PVco._, more than the simultaneous increase in vcan compensate for. The concentration effect of nitrous oxide on a second alveolar gas should only persist for a short time. Even though nitrous oxide concentration was increased by 10 per cent every 9,0 minutes it is doubtful that this mechanism could adequately explain the 5 to 6 torr average increase in Paco._, measured at 70 per cent nitrous oxide when compared to 100 per cent oxygen.
This leaves nitrous-oxide-induced increases in physiological dead space, increases in plasma catecholamines or both as the most likely causes of the increased Paeo2 observed. Unfortunately neither physiological dead space nor plasma catecholamines were measured during this study.
An interesting finding of this investigation was the significant depression in QT and increase in SVR which breathing 100 per cent oxygen produced in both NH and AH calves. These alterations have also been reported in man with oxygen, lr While the mechanism causing these changes is not entirely understood, it has been suggested that a significant component of the reduction in (~T is due to oxygeninduced metabolic depression of cardiac muscle, lr Similar recluctions in QT in NH and AH calves with 100 per cent oxygen breathing in this study, while not completely negating metabolic depression of cardiac muscle as a mechanism, suggest it is not a major explanation of the findings.
Alterations in QT after pharmacological administration in NH calves are dependent on changes in pre-load, after-load and the chronotropic and inotropic state of the heart. AH calves respond in a similar fashion except their chronotropic and inotropic states are fixed. Since nitrous oxide breathing produced no significant change in SVR and PVR in NH or AH calves at any time in this study, the significant difference in QT (with 40 to 70 per cent nitrous oxide breathing) between NH and AH calves can only be explained by alterations in pre-load or myocardial inotropy and/or chronotropy. The response of AH hearts to changes in venous return (pre-load) is similar to that of NH hearts. Therefore, the difference in QT between the two groups of animals during nitrous oxide "breathing must be due to direct or induced myocardial effects of breathing the gas. Nitrous oxide produced similar increases in stroke volume in NH and AH calves (+9 per cent and +7 per cent respectively at 70 per cent when compared to 100 per cent oxygen values) indicating that increased venous return is one mechanism by which the gas improves QT. However, nitrous oxide also increased HR 13 per cent in NH calves. The latter change represents the majority of the difference in QT between NH calves and AH calves that have a fixed HR. This suggests that nitrous oxide, or the consequence of breathing it, produces significant chronotropic stimulation. Since high (50 to 75 per cent) concentrations of nitrous oxide as well as 100 per cent oxygen have been shown to have little direct effect on myocardial chronotropy or inotropy in isolated myocardial tissue preparations, ~ these data, while not exactly elucidating the mechanism, provide additional support for the concept of indirect myocardial stimulation during nitrous oxide anaesthesia.
SUMMARY
Peripheral vascular and myocardial effects of increasing concentrations of nitrous oxide (0 to 70 per cent) in oxygen were determined in 15 unanaesthetized calves before and after replacement of their natural heart (NH) with a pneumatieally driven artificial heart (AH). Nitrous oxide produced concentration-related decreases in arterial and mixed venous pH and increases in minute ventilation and arterial and mixed venous carbon dioxide tensions in both NH and AH calves. Nitrous oxide resulted in significant increases in cardiac output, stroke volume and mean aortic, pulmonary artery and right atrial pressures in NH and AH calves, but did not significantly change systemic vascular resistance in either group of animals, Heart rate was increased in NH calves but was fixed in AH calves, Elevations in heart rate and cardiac output at nitrous oxide concentrations greater than 30 per cent and aortic pressure at 70 per cent nitrous oxide were significantly greater in NH than AH animals (P < 0,05). These data demonstrate that nitrous oxide stimulates the cardiovascular system in spontaneously breathing mammals and that the changes result fi'oni improved venous return and an increase in myocardial chronotropy. Our findings also suggest that cardiovascular stimulation during nitrous oxide breathing may be related to increased concentrations of arterial and/or venous carbon dioxide,
II~svMk
Nous avons ~tudi6 les effects cardiaques et vaseulaires p6riph6riques de concentrations croissantes de protoxyde d'azote (de 10 ~t 70 pour cent d'un m~lange protoxyde-oxyg~ne) chez le veau ~ l'6tat d'~veil, Cette 6rude a port6 chez l'animal normal et chez l'animal porteur d'un coeur artificiel actionn6 par un syst~me pneumatique, L'utilit6 d'une telle pr6paration animale pour l'6tude des effets cardiovasculaires d'agents pharmacologiques a ~t~ d~montr~e dins des rapports r~cents ~manant de notre laboratoire.
Nous avons observ~ chez 15 veaux soumis ~i eette ~tude, une augmentation des Pco.., art~rielles et veineuses suite ~ l'inhalation de protoxyde d'azote, et ceei chez les animaux normaux et chez les animaux porteurs d'un eeeur artificiel. L'inhalation de protoxyde produisait de plus, tant chez ranimal normal que chez l'animal ~t occur implant6, une augmentation du d~bit cardiaque, du volume d'6jection et des pressions moyennes au niveau de l'aorte, de l'art~re pulmonaire et de l'oreillette droite; la r6sistance p~riph~rique n'~tait pas modifi~e. La fr~quence eardiaque augmentait chez le veau normal et demeurait fixe chez le veau porteur de/'implant. Les 616vations de la fr6quence et du d~bit cardiaques que l'on a observ~es aux concentrations de protoxyde sup~rieures "~ 30 pour cent et les 61~vations de la pression aortique survenant ~ des concentrations de 70 pour cent 6taient significativement plus grandes ehez les animaux ~t coeur normal.
Nos r~sultats d~montrent que le protoxyde d'azote stimule le syst~me cardiovasculaire chez les animaux en respiration spontan6e et que les changements observ6s d~coulent d'une amelioration de retour veineux et d'une stinaulation chrouotrope. Nos r6sultats sugg~rent de plus que la stimulation cardiovaseulaire observ6e sous protoxyde d'azote est li6e '~ l'6l~vation de la Pco2 art6rielle et/ou veineuse.
